Life Sciences
Edwards Lifesciences Sends Positive Signals but Merits Wait-and-See Approach
The charts of the producer of medical technology show promise but could be derailed by weakness in the broader markets.
I've Got a Rough Floorplan for How to Play Blueprint Medicines
The charts for this drug developer are starting to take shape.
Edwards Lifesciences Offers Promise for Patients and Investors
Traders have been shifting from aggressive selling to aggressive buying.
This Won't Hurt a Bit: Moderna Could Rally 25% From Here
The stock is ready to make a recovery rally.
Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?
Let's check the charts on this biotechnology stock and see if it still has a prayer.
Little-Known Akoya Biosciences Appears to Have Found a Bottom
The stock of the life sciences company has found buying interest at a key support level.
Treat Becton, Dickinson and Company With Care
BDX gets an upgrade, but are the charts healthy enough to recommend?
Johnson & Johnson Appears to Be Running Out of Steam
The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.
Bearish Bets: 3 Stocks You Should Consider Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Medtronic Shares Appear to Be Bottoming
Aggressive traders of the medical device maker's stock could probe the long side on weakness, such as it is seeing after posting fiscal fourth-quarter results.